AUPR418701A0 - A drug for use in bone grafting - Google Patents

A drug for use in bone grafting

Info

Publication number
AUPR418701A0
AUPR418701A0 AUPR4187A AUPR418701A AUPR418701A0 AU PR418701 A0 AUPR418701 A0 AU PR418701A0 AU PR4187 A AUPR4187 A AU PR4187A AU PR418701 A AUPR418701 A AU PR418701A AU PR418701 A0 AUPR418701 A0 AU PR418701A0
Authority
AU
Australia
Prior art keywords
drug
bone grafting
grafting
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR4187A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Royal Alexandra Hospital for Children
Original Assignee
Royal Alexandra Hospital for Children
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Alexandra Hospital for Children filed Critical Royal Alexandra Hospital for Children
Priority to AUPR4187A priority Critical patent/AUPR418701A0/en
Publication of AUPR418701A0 publication Critical patent/AUPR418701A0/en
Priority to NZ527351A priority patent/NZ527351A/en
Priority to SK986-2003A priority patent/SK9862003A3/en
Priority to CA2435552A priority patent/CA2435552C/en
Priority to KR10-2003-7010328A priority patent/KR20030072399A/en
Priority to DK01273650.0T priority patent/DK1365769T3/en
Priority to RU2003127076/15A priority patent/RU2284821C2/en
Priority to PL36190901A priority patent/PL361909A1/en
Priority to CNB018225365A priority patent/CN1233325C/en
Priority to US10/470,924 priority patent/US7425549B2/en
Priority to EP01273650A priority patent/EP1365769B1/en
Priority to CZ20032408A priority patent/CZ301361B6/en
Priority to PCT/AU2001/001616 priority patent/WO2002062351A1/en
Priority to JP2002562358A priority patent/JP2004527479A/en
Priority to MXPA03007029A priority patent/MXPA03007029A/en
Priority to DE60143964T priority patent/DE60143964D1/en
Priority to AT01273650T priority patent/ATE496624T1/en
Priority to BR0116862-2A priority patent/BR0116862A/en
Priority to AU2002221339A priority patent/AU2002221339B2/en
Priority to HU0303013A priority patent/HUP0303013A3/en
Priority to SI200130991T priority patent/SI1365769T1/en
Priority to EP02712634A priority patent/EP1383509A4/en
Priority to NZ528659A priority patent/NZ528659A/en
Priority to PCT/AU2002/000412 priority patent/WO2002080933A1/en
Priority to JP2002578972A priority patent/JP2004526747A/en
Priority to US10/474,072 priority patent/US20040157798A1/en
Priority to AU2002244520A priority patent/AU2002244520B2/en
Priority to ZA2003/05890A priority patent/ZA200305890B/en
Priority to IL157201A priority patent/IL157201A/en
Priority to NO20033446A priority patent/NO20033446L/en
Priority to HK04103953.5A priority patent/HK1061797A1/en
Priority to US12/191,264 priority patent/US7612050B2/en
Priority to CY20111100406T priority patent/CY1111402T1/en
Abandoned legal-status Critical Current

Links

AUPR4187A 2001-02-06 2001-04-03 A drug for use in bone grafting Abandoned AUPR418701A0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
AUPR4187A AUPR418701A0 (en) 2001-04-03 2001-04-03 A drug for use in bone grafting
SI200130991T SI1365769T1 (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
AT01273650T ATE496624T1 (en) 2001-02-06 2001-12-13 MEDICINAL PRODUCTS FOR THE TREATMENT OF OSTEONECROSIS AND FOR THE CARE OF PATIENTS AT RISK OF DEVELOPING OSTEONECROSIS
AU2002221339A AU2002221339B2 (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
CA2435552A CA2435552C (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
BR0116862-2A BR0116862A (en) 2001-02-06 2001-12-13 Medication, methods to treat a patient with osteonecrosis and / or osteochondritis dissecans, to prevent osteonecrosis and / or osteochondritis dissecans in a patient at risk for each of said diseases, use of a medication, and, method to prevent cartilage destruction or chondrolysis associated with osteonecrosis and / or osteochondritis dissecans
DK01273650.0T DK1365769T3 (en) 2001-02-06 2001-12-13 Drug for the treatment of osteonecrosis and for the treatment of patients at risk of developing osteonecrosis
RU2003127076/15A RU2284821C2 (en) 2001-02-06 2001-12-13 Medicinal preparation for treating osteonecrosis and for treating patients at risk of osteonecrosis development
PL36190901A PL361909A1 (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
SK986-2003A SK9862003A3 (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
US10/470,924 US7425549B2 (en) 2001-02-06 2001-12-13 Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
EP01273650A EP1365769B1 (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
CZ20032408A CZ301361B6 (en) 2001-02-06 2001-12-13 Medicament for the treatment of osteonecrosis and osteochondritis dissecans
PCT/AU2001/001616 WO2002062351A1 (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
JP2002562358A JP2004527479A (en) 2001-02-06 2001-12-13 Medication for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
HU0303013A HUP0303013A3 (en) 2001-02-06 2001-12-13 A drug for treatment of osteonecrosis and for the management of patients at risk developing osteonecrosis
DE60143964T DE60143964D1 (en) 2001-02-06 2001-12-13 DRUGS TO TREAT OSTEONE COSMETICS AND TO SUPPLY PATIENTS WITH RISK TO OSTEONE CRYOSIS
NZ527351A NZ527351A (en) 2001-02-06 2001-12-13 Use of bisphosphonate for the treatment of osteonecrosis and for the management of patients at risk of developing ostenonecrosis
KR10-2003-7010328A KR20030072399A (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
CNB018225365A CN1233325C (en) 2001-02-06 2001-12-13 Drug for treatment of osteonecrosis and for management of patients at risk of evelopment osteonecrosis
MXPA03007029A MXPA03007029A (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis.
EP02712634A EP1383509A4 (en) 2001-04-03 2002-03-28 A drug for use in bone grafting
AU2002244520A AU2002244520B2 (en) 2001-04-03 2002-03-28 A drug for use in bone grafting
NZ528659A NZ528659A (en) 2001-04-03 2002-03-28 A drug for use in bone grafting
PCT/AU2002/000412 WO2002080933A1 (en) 2001-04-03 2002-03-28 A drug for use in bone grafting
JP2002578972A JP2004526747A (en) 2001-04-03 2002-03-28 Drugs used in bone transplantation
US10/474,072 US20040157798A1 (en) 2001-04-03 2002-03-28 Drug for use in bone grafting
ZA2003/05890A ZA200305890B (en) 2001-02-06 2003-07-30 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
IL157201A IL157201A (en) 2001-02-06 2003-07-31 Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
NO20033446A NO20033446L (en) 2001-02-06 2003-08-04 Medication for the treatment of osteonecrosis and for the treatment of patients at risk of developing osteonecrosis
HK04103953.5A HK1061797A1 (en) 2001-02-06 2004-06-02 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
US12/191,264 US7612050B2 (en) 2001-02-06 2008-08-13 Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
CY20111100406T CY1111402T1 (en) 2001-02-06 2011-04-20 MEDICINE FOR OSTONEECONOMY TREATMENT AND FOR MANAGEMENT OF PATIENT MECHANISMS OF OSTONEECONOSIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR4187A AUPR418701A0 (en) 2001-04-03 2001-04-03 A drug for use in bone grafting

Publications (1)

Publication Number Publication Date
AUPR418701A0 true AUPR418701A0 (en) 2001-05-03

Family

ID=3828187

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR4187A Abandoned AUPR418701A0 (en) 2001-02-06 2001-04-03 A drug for use in bone grafting

Country Status (1)

Country Link
AU (1) AUPR418701A0 (en)

Similar Documents

Publication Publication Date Title
EP1383509A4 (en) A drug for use in bone grafting
AUPR969201A0 (en) A device for use in intraluminal grafting
AU9517301A (en) Implant
AU2002328762A1 (en) Osteophilic implants
AU2002339993A1 (en) P-amidobenzylethers in drug delivery agents
AU2001281758A1 (en) Biocompatible materials
AU2002256018A1 (en) Overall risk in a system
AU2001254786A1 (en) Medical implant
AU2001263841A1 (en) Implant
AU2001270206A1 (en) Dental implant
AU2002253039A1 (en) Tramadol-based medicament
AU2002315080A1 (en) Bone plates
AU2002259329A1 (en) Medical grafting apparatus
AU2001256201A1 (en) Device for administering implants
AU2002210298A1 (en) Dental implant
AU2002321019A1 (en) Bone implant
AU2001240557A1 (en) Implant for cranioplastics
AU2001266282A1 (en) Sterilization apparatus
AU2002241065A1 (en) Heterocarpine, a human GHRH-binding protein
AUPR960001A0 (en) A syringe
AUPR961301A0 (en) A drug for use in bone grafting
AUPR418701A0 (en) A drug for use in bone grafting
AU2002315198A1 (en) Tissue dispenser
AU2002327878B2 (en) Container for using for dialysis
AU2003217043A1 (en) Delivery assembly for use in surgery